AstraZeneca Settlement Has Consumer Class Split

Law360, New York (June 8, 2007, 12:00 AM EDT) -- U.S. consumers who agreed to a $24 million settlement with AstraZeneca in a long-running battle with pharmaceutical companies over wholesale drug prices are now fighting one of their own, who has argued the class could get a better deal.

Lead counsel for the plaintiffs in the multidistrict litigation have argued that the objections of class representative Joyce Howe display a “fundamental misunderstanding” of the settlement's terms and are driven chiefly by her attorney's “self-interest.”

On May 22 the court gave its preliminary approval to the proposed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.